Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 104

Tests names and labsConditionsGenes, analytes, and microbesMethods

CYP2C19

Invitae
United States
21
  • T Targeted variant analysis

CYP2C19

Department of Laboratory Medicine P.D. Hinduja National Hospital - MRC
India
12
  • T Targeted variant analysis

CYP2C19-Related Disorders via the CYP2C19 Gene

PreventionGenetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CYP2C19 (CYP2C19 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

CYP2C19

Aventus Biolabs
United States
11
  • T Targeted variant analysis

CYP2C19

Millennium Health
United States
82
  • T Targeted variant analysis

CYP2C19-related poor drug metabolism (sequence analysis of CYP2C19 gene)

CGC Genetics
Portugal
11
  • C Sequence analysis of the entire coding region

CYP2C19

ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories
United States
11
  • T Targeted variant analysis

CYP2C19

MVZ Dr. Eberhard & Partner Dortmund
Germany
11
  • E Sequence analysis of select exons

Cytochrome P450 (deletion/duplication analysis on CYP2D6, CYP2C9, CYP2C19, CYP1B1, CYP3A4, CYP3A5, CYP2E1, CYP1A1, CYP1A2, CYP2A6, CYP2B6 genes)

CGC Genetics
Portugal
1311
  • D Deletion/duplication analysis

CYP2C19, major genotyping

Molecular Diagnostics Laboratory Seoul National University Hospital
South Korea
11
  • E Sequence analysis of select exons

CYP2C19 Genotyping

IU Genetic Testing Laboratories Indiana University School of Medicine
United States
11
  • T Targeted variant analysis

Clopidogrel, impaired responsiveness to, 609535, Autosomal recessive (Resistance to clopidogrel) (CYP2C19 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

Mephenytoin poor metabolizer, 609535, Autosomal recessive (Resistance to clopidogrel) (CYP2C19 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

Proguanil poor metabolizer, 609535, Autosomal recessive (Resistance to clopidogrel) (CYP2C19 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

Omeprazole poor metabolizer, 609535, Autosomal recessive (Resistance to clopidogrel) (CYP2C19 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

CYP2C19 drug metabolizing enzyme gene mutation

Molecular Diagnostics Children's Hospital of Wisconsin
United States
11
  • T Targeted variant analysis

AccuType(R) CP, Clopidogrel CYP2C19 Genotype

Quest Diagnostics Nichols Institute San Juan Capistrano
United States
11
  • T Targeted variant analysis

CYP2C19 Single Gene

Fulgent Genetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CYP2C19, Genotyping

Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University
United States
11
  • T Targeted variant analysis

Results: 1 to 20 of 104

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center